Assessment of thyroid lesions (general)

Changed by Matt A. Morgan, 20 Apr 2016

Updates to Article Attributes

Body was changed:

Assessment of thyroid lesions is commonly encountered in radiological practice.

Thyroid mass breakdown
Risk factors of a nodule being malignant
  • young
  • male
  • solitary
  • cold on thyroid scan
  • past history of radiotherapy

The first three risk factors are really a reflection that elderly women with multiple benign thyroid nodules are very common.

Radiographic features

Ultrasound
  • taller-than-wide in axial/transverse dimension, microcalcifications, local invasiveness, microlobulated contour, and hypoechogenicity are suspicious features
  • size criteria are controversial and continously evolving
  • cervical lymphadenopathy is a suspicious feature
  • for detailed assessment, see: assessment of thyroid lesions (ultrasound)
Nuclear medicine

A single 'cold' nodule has a 10% chance of being malignant. A single 'hot' nodule has <1% chance of being malignant.

Treatment and prognosis

Indications for FNA

The criteria developed by the American Thyroid Association (2015) 11 are often used in clinical practice. See: ATA guidelines for assessment of thyroid nodules.

Indications for FNA according to Society of Radiologists in Ultrasound (2008) 4

  • nodule ≥1.0 cm at the largest diameter if microcalcifications are present
  • nodule ≥1.5 cm if the nodule is solid or if there are coarse calcifications within the nodule

Additional recommendations for FNA by the American Association of Clinical Endocrinologists 4:

  • FNA recommended for nodules <`10 mm whenever clinical information or ultrasound features raises suspicion about the presence of a malignancy

Size criteria for indication for FNA according American Thyroid Association (2015) 11:

  • FNA is recommended for:
    • nodules ≥1 cm with highly or intermediately suspicious sonographic features
    • nodules ≥1.5 cm with low suspicious sonographic features
  • FNA may be considered for:
    • nodules ≥2 cm with very low suspicious sonographic features
      • observation is an alternative
  • FNA is not required for:
    • nodules not meeting above criteria
    • purely cystic nodules

High risk factors:

  • history of childhood head and neck irradiation
  • family history of thyroid cancer or a thyroid cancer syndrome
  • prior hemithyroidectomy with discovery of thyroid cancer
  • increased activity on PET scan
  • presence of MEN2-associated oncogene
Management of FNA results
  • benign: clinical and imaging follow up
  • follicular neoplasm
  • atypia of uncertain significance / follicular lesion of uncertain significance (AUS/FLUS)
    • 3-6%
    • repeat FNA
      • two samples obtained at second biopsy
      • if AUS/FLUS again (~20%) on the first sample, then the risk of malignancy is 5-15% 10
      • the second sample may be sent for gene sequencing, if available (gene expression classifier)
        • if benign, then normal clinical and imaging follow up
        • if suspicious, 50% risk of malignancy
  • malignant: partial or total thyroidectomy with lymph node exploration
Staging
  • -<li>size criteria are controversial</li>
  • -<li>cervical <a href="/articles/lymph-node-enlargement">lymphadenopathy</a> is a suspicious feature</li>
  • +<li>size criteria are controversial and continously evolving</li>
  • +<li>cervical <a href="/articles/lymph-node-enlargement">lymphadenopathy</a> is a feature</li>
  • -</ul><h5>Nuclear medicine</h5><p>A single 'cold' nodule has a 10% chance of being malignant. A single 'hot' nodule has &lt;1% chance of being malignant.</p><h4>Treatment and prognosis</h4><h5>Indications for FNA</h5><p>Indications for FNA according to <strong>Society of Radiologists in Ultrasound </strong>(2008) <sup>4</sup></p><ul>
  • +</ul><h5>Nuclear medicine</h5><p>A single 'cold' nodule has a 10% chance of being malignant. A single 'hot' nodule has &lt;1% chance of being malignant.</p><h4>Treatment and prognosis</h4><h5>Indications for FNA</h5><p>The criteria developed by the <strong>American Thyroid Association</strong> (2015) <sup>11</sup> are often used in clinical practice. See: <a title="ATA guidelines for assessment of thyroid nodules" href="/articles/ata-guidelines-for-assessment-of-thyroid-nodules">ATA guidelines for assessment of thyroid nodules</a>.</p><p>Indications for FNA according to <strong>Society of Radiologists in Ultrasound </strong>(2008) <sup>4</sup></p><ul>
  • -</ul><p>Additional recommendations for FNA by the American Association of Clinical Endocrinologists <sup>4</sup>:</p><ul><li>FNA recommended for nodules &lt;`10 mm whenever clinical information or ultrasound features raises suspicion about the presence of a malignancy</li></ul><p>Size criteria for indication for FNA according <strong>American Thyroid Association</strong> (2015) <sup>11</sup>:</p><ul>
  • -<li>FNA is recommended for:<ul>
  • -<li>nodules ≥1 cm with highly or intermediately suspicious sonographic features</li>
  • -<li>nodules ≥1.5 cm with low suspicious sonographic features</li>
  • -</ul>
  • -</li>
  • -<li>FNA may be considered for:<ul><li>nodules ≥2 cm with very low suspicious sonographic features<ul><li>observation is an alternative</li></ul>
  • -</li></ul>
  • -</li>
  • -<li>FNA is not required for:<ul>
  • -<li>nodules not meeting above criteria</li>
  • -<li>purely cystic nodules</li>
  • -</ul>
  • -</li>
  • -</ul><p>High risk factors:</p><ul>
  • -<li>history of childhood head and neck irradiation</li>
  • -<li>family history of thyroid cancer or a thyroid cancer syndrome</li>
  • -<li>prior hemithyroidectomy with discovery of thyroid cancer</li>
  • -<li>increased activity on PET scan</li>
  • -<li>presence of <a title="MEN II" href="/articles/multiple-endocrine-neoplasia-type-ii-1">MEN2</a>-associated oncogene</li>
  • -</ul><h5>Management of FNA results</h5><ul>
  • +</ul><p>Additional recommendations for FNA by the American Association of Clinical Endocrinologists <sup>4</sup>:</p><ul><li>FNA recommended for nodules &lt;`10 mm whenever clinical information or ultrasound features raises suspicion about the presence of a malignancy</li></ul><p> </p><h5>Management of FNA results</h5><ul>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.